510(k) Report

PMA · Approved

Recalled · Class I · 2025

Tack Endovascular System (6F)

P180034PMAApproved Apr 11, 2019223-day reviewClass IIIRecalls 1 (1 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Philips Image Guided Therapy Corporation · QCT Scaffold, Dissection Repair

Approved on Apr 11, 2019 through premarket approval, which rests on the device’s own clinical evidence after a 223-day review. It has a Class I recall. It has been recalled once, including a Class I recall.

Decided
Apr 11, 2019
Review
223 days
Class
Class III
Product code
QCT
Recalls
1 (1 Class I)

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P180034 has 7 supplements since 2020: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2020: 32021: 22022: 2
2020high 3 (2020) · low 2 (2021)2022
View FIG. 1 as a table
YearSupplements approved
20203
20212
20222
FIG. 1 — Supplements to P180034, 2020–2022Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 10, 2025Class IZ-1070-2025Device DesignUse of Tack Endovascular system, designed to treat acute dissections of inner wall or lining of an artery by tacking damaged tissue to inner luminal surface, could result in problems with deployment and stability of device in vessel after…

No ancestor or descendant has a Class I recall.

How does its category compare?

All QCT devices

QCT Scaffold, Dissection Repair: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · QCT

5in 2022

2019: 12020: 52021: 32022: 5
2007high 5 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QCT

Too few QCT 510(k)s in any year since 2007 to give a median.

Recalls per year · QCT

1in 2025

2025: 1, 1 Class I
2007high 1 (2025) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · QCT

1in 2025

2019: 12020: 32021: 62022: 22023: 12024: 4642025: 1
2007high 464 (2024) · low 0 (2007)2025

MAUDE reports naming product code QCT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20191—01
20205—03
20213—06
20225—02
20230—01
20240—0464
20250—1 (1)1
20260—0—
Cite this page

510(k) Report. “P180034: Tack Endovascular System (6F).” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P180034

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026